The estimated Net Worth of Karen Noblett is at least 6.93 百万$ dollars as of 31 January 2024. Dr Noblett owns over 27,500 units of Axonics Inc stock worth over 3,142,061$ and over the last 6 years he sold AXNX stock worth over 3,132,085$. In addition, he makes 651,400$ as Chief Medical Officer at Axonics Inc.
Dr has made over 9 trades of the Axonics Inc stock since 2019, according to the Form 4 filled with the SEC. Most recently he exercised 27,500 units of AXNX stock worth 1,890,075$ on 31 January 2024.
The largest trade he's ever made was exercising 32,483 units of Axonics Inc stock on 12 September 2022 worth over 623,349$. On average, Dr trades about 15,208 units every 165 days since 2019. As of 31 January 2024 he still owns at least 45,716 units of Axonics Inc stock.
You can see the complete history of Dr Noblett stock trades at the bottom of the page.
Dr. Karen L. Noblett M.D., M.A.S. is the Chief Medical Officer at Axonics Inc.
As the Chief Medical Officer of Axonics Inc, the total compensation of Dr S at Axonics Inc is 651,400$. There are 5 executives at Axonics Inc getting paid more, with Raymond Cohen having the highest compensation of 6,147,640$.
Dr S is 58, he's been the Chief Medical Officer of Axonics Inc since . There are 7 older and 13 younger executives at Axonics Inc. The oldest executive at Axonics Inc is Nancy Snyderman, 68, who is the Independent Director.
Karen's mailing address filed with the SEC is 26, Technology Drive, Irvine Spectrum, Irvine, Orange County, California, 92618, United States.
Over the last 6 years, insiders at Axonics Inc have traded over 108,010,643$ worth of Axonics Inc stock and bought 4,672,163 units worth 70,180,620$ . The most active insiders traders include Asset Management, Lp Chen B...、Shahzad Malik、Geoff Pardo. On average, Axonics Inc executives and independent directors trade stock every 15 days with the average trade being worth of 4,280,711$. The most recent stock trade was executed by Raymond W Cohen on 24 July 2024, trading 103,896 units of AXNX stock currently worth 2,383,374$.
axonics modulation technologies, inc is a privately-held medical device company developing an innovative neuromodulation platform based on a miniaturized rechargeable fully-implantable ipg licensed from the alfred mann foundation. the axonics sacral neuromodulation system is designed to improve the experience of both clinicians and patients suffering from urinary and fecal dysfunction.
Axonics Inc executives and other stock owners filed with the SEC include: